Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus

New human cytomegalovirus (HCMV) therapies with novel mechanisms of action are needed to treat drug-resistant HCMV that arises during therapy with currently approved agents. 2-Bromo-5,6-dichloro-1-β-d-ribofuranosyl-1H-benzimidazole (BDCRB) is an effective anti-HCMV agent with a novel mechanism of ac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Underwood, Mark R., Ferris, Robert G., Selleseth, Dean W., Davis, Michelle G., Drach, John C., Townsend, Leroy B., Biron, Karen K., Boyd, F. Leslie
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2004
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC400548/
https://ncbi.nlm.nih.gov/pubmed/15105116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1647-1651.2004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares